138 related articles for article (PubMed ID: 25208478)
1. Familial gliomas: cases in two pairs of brothers.
Osorio JA; Hervey-Jumper SL; Walsh KM; Clarke JL; Butowski NA; Prados MD; Berger MS
J Neurooncol; 2015 Jan; 121(1):135-40. PubMed ID: 25208478
[TBL] [Abstract][Full Text] [Related]
2. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.
Sadetzki S; Bruchim R; Oberman B; Armstrong GN; Lau CC; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut J; Johansen C; Houlston RS; Shete S; Amos CI; Bernstein JL; Olson SH; Jenkins RB; Lachance D; Vick NA; Merrell R; Wrensch M; Davis FG; McCarthy BJ; Lai R; Melin BS; Bondy ML;
Eur J Cancer; 2013 Apr; 49(6):1335-45. PubMed ID: 23290425
[TBL] [Abstract][Full Text] [Related]
3. High frequency of the X-chromosome inactivation in young female patients with high-grade glioma.
Li G; Zhang Z; Jin T; Liang H; Tu Y; Gong L; Chen Z; Gao G
Diagn Pathol; 2013 Jun; 8():101. PubMed ID: 23782947
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
[TBL] [Abstract][Full Text] [Related]
5. Familial glioma: a report of glioblastoma in identical twins and oligo-astrocytoma in siblings.
Hardman PD; Bell J; Whittle IR; Gregor A
Br J Neurosurg; 1989; 3(6):709-15. PubMed ID: 2697216
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML
Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405
[TBL] [Abstract][Full Text] [Related]
7. Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts.
Broniscer A; Hwang SN; Chamdine O; Lin T; Pounds S; Onar-Thomas A; Chi L; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
Brain Pathol; 2018 Jan; 28(1):112-120. PubMed ID: 28032389
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.
Kong LW; Chen J; Zhao H; Yao K; Fang SY; Wang Z; Wang YY; Li SW
Sci Rep; 2019 Nov; 9(1):17080. PubMed ID: 31745161
[TBL] [Abstract][Full Text] [Related]
9. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
[TBL] [Abstract][Full Text] [Related]
10. Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA).
Almuhaisen G; Alhalaseh Y; Mansour R; Abu-Shanab A; Al-Ghnimat S; Al-Hussaini M
Brain Tumor Pathol; 2021 Jan; 38(1):14-22. PubMed ID: 32897465
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
Shete S; Lau CC; Houlston RS; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Sadetzki S; Johansen C; Bernstein JL; Olson SH; Jenkins RB; Yang P; Vick NA; Wrensch M; Davis FG; McCarthy BJ; Leung EH; Davis C; Cheng R; Hosking FJ; Armstrong GN; Liu Y; Yu RK; Henriksson R; ; Melin BS; Bondy ML
Cancer Res; 2011 Dec; 71(24):7568-75. PubMed ID: 22037877
[TBL] [Abstract][Full Text] [Related]
12. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas.
McCord M; Steffens A; Javier R; Kam KL; McCortney K; Horbinski C
Acta Neuropathol Commun; 2020 Feb; 8(1):15. PubMed ID: 32051040
[TBL] [Abstract][Full Text] [Related]
15. Pediatric low-grade gliomas: how modern biology reshapes the clinical field.
Bergthold G; Bandopadhayay P; Bi WL; Ramkissoon L; Stiles C; Segal RA; Beroukhim R; Ligon KL; Grill J; Kieran MW
Biochim Biophys Acta; 2014 Apr; 1845(2):294-307. PubMed ID: 24589977
[TBL] [Abstract][Full Text] [Related]
16. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
[TBL] [Abstract][Full Text] [Related]
18. Glioma models.
Dai C; Holland EC
Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
[TBL] [Abstract][Full Text] [Related]
19. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.
Malmer B; Henriksson R; Grönberg H
Neuroepidemiology; 2002; 21(6):279-86. PubMed ID: 12411730
[TBL] [Abstract][Full Text] [Related]
20. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
